Article & News

NEW DELHI: A citizen-funded quality study of commonly prescribed medicines has found no difference in quality between expensive branded drugs and the far cheaper generics,

The decision follows a proposal by the CDSCO, top internal advisory body-the Drugs Consultative Committee (DCC), which at its 67th meeting last month had also

Facing mount­ing scru­tiny over drug safety lapses, India is work­ing to over­haul its phar­ma­ceut­ical licens­ing frame­work by intro­du­cing a sep­ar­ate whole­sale licens­ing regime for bulk

At least 15 drug­makers are in the fray to tap the estim­ated ₹5,000 crore oppor­tun­ity emer­ging from sema­glu­tide’s pat­ent expiry, but the road to for­eign

The upward trajectory of weight-loss and diabetes drugs continues, as Eli Lilly’s Mounjaro clocks sales of over ₹100 crore in December 2025 – making it

More than 60% of India’s small and medium pharmaceutical enterprises (SMEs) face a potential shutdown by December 31, 2025, following non-compliance with revised Good Manufacturing

A leading thinker in the field of aging research, Dr. David Sinclair, shares insights on the rapid pace of advancements in aging research and predicts

When the world was gripped by uncertainty during the COVID-19 pandemic, vaccines became more than a medical solution. They turned into a measure of global

Indian drug­makers such as Dr. Reddy’s and Sun Phar­ma­ceut­ical Indus­tries are already play­ing catch-up with Bangladesh, even as they pre­pare to enter the global mar­ket

Mumbai, Dec 19 (UNI) A special NDPS court here has sentenced two pharmacists to 20 years of Rigorous Imprisonment and levied a fine of Rs